|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27,cyclin D1,and antitumor action显示文摘 | Yakes FM Chinratanalab W Ritter CA | 2002 | Cancer Res2002，62，14： | 1 |
| 2 | Herceptininduced inhibition of Phosphatidylinositol-3 Kinase and Akt is required for antibody-mediated effects on p27, Cyclin D1, and antitumor action显示文摘 | Yakes FM Chinratanalab W Ritter CA | 2002 | Cancer Res2002，62，14： | 1 |
| 3 | Motochodrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells follwing oxidative stress显示文摘 | Yakes FM Vonhouten B | 1997 | Proc natl Acad Sci USA1997，94，2： | 1 |
| 4 | Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth显示文摘 | Yakes FM Chen J Tan J | 2011 | Mol Cancer Ther2011，10，12： | 1 |
| 5 | PKB/Akt mediates cellcycle progression by phosphorylation of P27 at threonine 157 and modulation of its cellular localization 显示文摘 | Shin I Yakes FM Rojo F | 2002 | Nature Med2002，8，10： | 1 |
| 6 | Herceptin-induced inhibition of Phosphatidytinositol-3 Kinase and Akt is required for antibody-mediated effects on p27, Cyclin Dl and antitumor action 显示文摘 | Yakes FM Chinratanalab W Ritter CA | 2002 | Cancer Res2002，62，14： | 1 |
| 7 | CM101 treatment overrides tumor-induced immunoprivilege leading to apoptosis显示文摘 | Yakes FM Wamil FD Sun F | 2000 | Cancer Res2000，60，： | 1 |
| 8 | Epidermal growth factor receptor ( HER1 ) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo 显示文摘 | Moulder SL Yakes FM Muthuswamy SK | 2001 | Cancer Res2001，61，： | 1 |
| 9 | Erb2/neu kinase modulates cellular P27 and cyclin D1 through multiple signaling pathways显示文摘 | Lenferink AE Flanagan WM Yakes FM | 2001 | Cancer Res2001，61，17： | 1 |
| 10 | Cabozantinib(XL184),a novel MET and VEGFR2 inhibitor,simultaneously suppresses metastasis,angiogenesis,and tumor growth显示文摘 | Yakes FM Chen J Tan J | 2011 | Mol Cancer Ther2011，10，12： | 1 |
| 11 | PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation ofits cellular localization显示文摘 | Shin I Yakes FM Rojo F | 2002 | Nat Med2002，8，10： | 1 |
| 12 | Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth 显示文摘 | Yakes FM Chen J Tan J | 2011 | Mol Cancer Ther2011，10，12： | 1 |
| 13 | Cabozantinib (XL184) , a novel MET and VEGFR2 inhibitor, simuhaneously suppresses metastasis, angiogenesis, and tumor growth 显示文摘 | YAKES FM CHEN J TAN J | 2011 | Mol Cancer T- her2011，10，12： | 1 |
| 14 | Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress 显示文摘 | Yakes FM Van Houten B | 1997 | Proc Natl Acad Sci USA1997，94，2： | 1 |
| 15 | Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo显示文摘 | Moulder SL Yakes FM Muthuswamy SK | | 0，，： | 1 |
| 16 | Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metas- tasis, angiogenesis, and tumor growth 显示文摘 | Yakes FM Chen J Tan J | 2011 | Mol Cancer Ther2011，10，12： | 1 |
| 17 | Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress 显示文摘 | Yakes FM Van Houten B | 1997 | Proc Natl Acad Sci USA1997，94，： | 1 |
| 18 | Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human ceils following oxidative stress显示文摘 | Yakes FM Van Houten B | 1997 | Proc Natl Acad Sci U S A1997，，4： | 1 |
| 19 | Cabozantinib(XL184), a novel met and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth 显示文摘 | Yakes FM Chen J Tan J | 2011 | Mol Cancer Ther2011，10，12： | 1 |
| 20 | HER(erbB)tyrosine kinase inhibitors in the treatment fo breast cancer显示文摘 | Arteaga CL Moulder SL yakes FM | 2002 | Semin Oncol2002，29，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员